Press Releases

2024 2023 2022 2021 2020 Show all
11.03.2024

MIG Capital leads €5 million Series A financing of animal healthcare company HawkCell to democratise MRI imaging

To Article Download
15.02.2024

MIG Capital announces stable development in fiscal year 2023, optimistic outlook for 2024

To Article Download
22.06.2023

MIG Capital co-leads seed investment in French space tech company Look Up Space

To Article Download
17.05.2023

MIG Capital strengthens its investment team with four new professionals

To Article Download
04.04.2023

MIG Capital participates in €54 million Series C extension round for AMSilk

To Article Download
28.03.2023

MIG Capital leads €15 million financing round for talpasolutions with Robert Bosch Venture Capital

To Article Download
23.03.2023

MIG Capital leads €13 million Series A financing of microbiome therapeutics biotech mbiomics

To Article Download
22.02.2023

MIG Capital on the 2022 financial year

To Article Download
09.02.2023

Financing round 130 million euros to APK

To Article Download
09.02.2023

Financing round 130 million euros to APK

To Article Download
27.04.2022

MIG Capital continues to grow after excellent financial year 2021

To Article
09.03.2022

MIG Capital leads seed financing for French start-up Inbolt

To Article
15.12.2021

MIG Capital leads €22.5 million Series B financing for Mimi Hearing Technologies

To Article Download
05.10.2021

MIG Fonds leads €65 million Series B financing of iOmx Therapeutics

To Article
04.10.2021

MIG sells portfolio company Hemovent to MicroPort

To Article
11.05.2021

MIG portfolio company AMSilk completes €29 million financing round

To Article
24.02.2021

Creative Balloons closes €15 million growth financing and appoints Frank Gehres as CEO

To Article
12.02.2021

Germany’s MIG Fonds makes first French investment with deep-tech company Zadient Technologies

To Article
21.12.2020

European innovation reaches EU population: MIG Fonds` portfolio company BioNTech achieves positive CHMP opinion for the first COVID-19 and mRNA vaccine

To Article

Press review

2024 2023 2022 2021 2020 Show all
/ 17.12.2020

Vaccine maker recounts “breakfast table” pivot to covid work

In einem Artikel von „AP news“ über die BioNTech Gründer Ugur Sahin und Özlem Türeci wird Matthias Kromayer, Managing Partner der MIG AG zitiert.
To Article Download

Press contact

Dr. Klaus Westermeier Medienbüro Römerstraße 4 80801 München
Tel. +49 172 843 32 32 presse@mig.ag